TLSA Proactive 4 days ago Tiziana reports biomarker gains for nasal MS therapy in progressive disease
TLSA Mining Technology 4 days ago Project ramp-ups and capacity expansions to increase Australian coal output in 2026
TLSA GlobeNewswire 4 days ago Bullhorn GRID report: Staffing firms using AI see stronger growth, faster placements
TLSA GuruFocus.com 4 days ago Magnora ASA (SVMRF) Q4 2025 Earnings Call Highlights: Strategic Shifts and Financial Resilience ... 📈 AI Sentiment Highly Positive 8/10
TLSA GuruFocus.com 4 days ago Ipsos SA (FRA:IPZ) Full Year 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges 📊 AI Sentiment Positive 6/10
TLSA StockStory 4 days ago Life Insurance Q4 Earnings: Corebridge Financial (NYSE:CRBG) is the Best in the Biz 📉 AI Sentiment Negative 3/10
TLSA GuruFocus.com 4 days ago HSBC Holdings PLC (HSBC) Full Year 2025 Earnings Call Highlights: Record Profits and Strategic ...
TLSA GuruFocus.com 4 days ago Verallia (WBO:VRLA) Q4 2025 Earnings Call Highlights: Navigating Challenges with Strategic ...
TLSA GuruFocus.com 4 days ago OPmobility (PASTF) Full Year 2025 Earnings Call Highlights: Strong Financial Performance Amidst ...
TLSA GlobeNewswire 4 days ago Tiziana Life Sciences Announces New Biomarker Data Showing Nasal Foralumab Downregulates CSF Inflammation, Upregulates Neuroprotective Pathways, and Correlates with Reduced Microglial Activation on PET Scans in na-SPMS Patients with PIRA